SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · IEX Real-Time Price · USD
4.800
-0.050 (-1.03%)
Apr 18, 2024, 4:30 PM EDT - Market closed
Company Description
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space.
The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.
SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
SOPHiA GENETICS SA
| Country | Switzerland |
| Founded | 2011 |
| IPO Date | Jul 23, 2021 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 430 |
| CEO | Dr. Jurgi Camblong M.B.A., Ph.D. |
Contact Details
Address: La Piece, Ch-1180 Rolle, V8 00000 Switzerland | |
| Phone | 41 21 694 10 60 |
| Website | sophiagenetics.com |
Stock Details
| Ticker Symbol | SOPH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 0001840706 |
| CUSIP Number | H82027105 |
| ISIN Number | CH1125843347 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder, Chief Executive Officer and Director |
| Ross Jordan Muken B.Sc. | Executive Vice President, Chief Financial Officer and Chief Operating Officer |
| Abhimanyu Verma | Senior Vice President and Chief Technology Officer |
| Dr. Zhenyu Xu Ph.D. | Executive Vice President and Chief Scientific Officer |
| Katherine Bailon | Vice President of Investor Relations |
| Daan van Well L.L.M., M.B.A. | Executive Vice President, Chief Legal and Compliance Officer |
| Manuela Da Silva Valente B.A. | Senior Vice President and Chief People Officer |
| Kevin Puylaert | Vice President and MD of EMEA |
| Dr. Philippe Menu M.B.A., M.D., Ph.D. | Executive Vice President, Chief Medical Officer and Chief Product Officer |
| Peter Casasanto | Senior Vice President and Chief BioPharma Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2024 | 144 | Filing |
| Apr 10, 2024 | 144 | Filing |
| Apr 10, 2024 | 144 | Filing |
| Apr 10, 2024 | 144 | Filing |
| Apr 10, 2024 | 144 | Filing |
| Apr 10, 2024 | 144 | Filing |
| Apr 8, 2024 | 144 | Filing |
| Apr 3, 2024 | 144 | Filing |
| Apr 3, 2024 | 144 | Filing |
| Apr 3, 2024 | 144 | Filing |